Lymphoscintigraphy for Imaging of the Lymphatic Flow Disorders.
Identifieur interne : 000455 ( PubMed/Corpus ); précédent : 000454; suivant : 000456Lymphoscintigraphy for Imaging of the Lymphatic Flow Disorders.
Auteurs : Rie Yagi Yoshida ; Shuji Kariya ; Sangkil Ha-Kawa ; Noboru TanigawaSource :
- Techniques in vascular and interventional radiology [ 1557-9808 ] ; 2016.
English descriptors
- KwdEn :
- Female, Humans, Lymphatic Diseases (diagnostic imaging), Lymphatic Diseases (etiology), Lymphatic Diseases (physiopathology), Lymphatic System (diagnostic imaging), Lymphatic System (physiopathology), Lymphoscintigraphy (adverse effects), Lymphoscintigraphy (instrumentation), Lymphoscintigraphy (methods), Male, Middle Aged, Predictive Value of Tests, Prognosis, Radiopharmaceuticals (administration & dosage), Risk Factors, Severity of Illness Index.
- MESH :
- chemical , administration & dosage : Radiopharmaceuticals.
- adverse effects : Lymphoscintigraphy.
- diagnostic imaging : Lymphatic Diseases, Lymphatic System.
- etiology : Lymphatic Diseases.
- instrumentation : Lymphoscintigraphy.
- methods : Lymphoscintigraphy.
- physiopathology : Lymphatic Diseases, Lymphatic System.
- Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Risk Factors, Severity of Illness Index.
Abstract
Lymphoscintigraphy has introduced with the great advantage for diagnostic imaging of the lymphatic flow disorders. Lymphoscintigraphy can be performed in patients of any age, including neonates, and even in patient in critical conditions. The procedure is quite simple, and it needs only subcutaneous injection of small amounts of radiotracers. From subcutaneous tissue the radiotracer is taken by the lymphatic vessels and gives off energy in the form of gamma radiation detected by a gamma camera. Radiotracers rarely cause the allergic reaction and can be administered to the patients with allergy to iodine contrast media. Comparing with the Lipiodol, radiotracers cannot cause pulmonary embolism; therefore, it is safe for the patients with respiratory dysfunction. The objective of this article is to describe the indication, technique, equipment, pitfalls, safety, and effectiveness of lymphoscintigraphy for imaging of the lymphatic flow disorders.
DOI: 10.1053/j.tvir.2016.10.009
PubMed: 27993322
Links to Exploration step
pubmed:27993322Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lymphoscintigraphy for Imaging of the Lymphatic Flow Disorders.</title><author><name sortKey="Yoshida, Rie Yagi" sort="Yoshida, Rie Yagi" uniqKey="Yoshida R" first="Rie Yagi" last="Yoshida">Rie Yagi Yoshida</name><affiliation><nlm:affiliation>Department of Radiology, Kansai Medical University, Hirakata, Osaka, Japan. Electronic address: yagir@hirakata.kmu.ac.jp.</nlm:affiliation></affiliation></author><author><name sortKey="Kariya, Shuji" sort="Kariya, Shuji" uniqKey="Kariya S" first="Shuji" last="Kariya">Shuji Kariya</name><affiliation><nlm:affiliation>Department of Radiology, Kansai Medical University, Hirakata, Osaka, Japan.</nlm:affiliation></affiliation></author><author><name sortKey="Ha Kawa, Sangkil" sort="Ha Kawa, Sangkil" uniqKey="Ha Kawa S" first="Sangkil" last="Ha-Kawa">Sangkil Ha-Kawa</name><affiliation><nlm:affiliation>Department of Radiology, Kansai Medical University, Hirakata, Osaka, Japan.</nlm:affiliation></affiliation></author><author><name sortKey="Tanigawa, Noboru" sort="Tanigawa, Noboru" uniqKey="Tanigawa N" first="Noboru" last="Tanigawa">Noboru Tanigawa</name><affiliation><nlm:affiliation>Department of Radiology, Kansai Medical University, Hirakata, Osaka, Japan.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27993322</idno><idno type="pmid">27993322</idno><idno type="doi">10.1053/j.tvir.2016.10.009</idno><idno type="wicri:Area/PubMed/Corpus">000455</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000455</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Lymphoscintigraphy for Imaging of the Lymphatic Flow Disorders.</title><author><name sortKey="Yoshida, Rie Yagi" sort="Yoshida, Rie Yagi" uniqKey="Yoshida R" first="Rie Yagi" last="Yoshida">Rie Yagi Yoshida</name><affiliation><nlm:affiliation>Department of Radiology, Kansai Medical University, Hirakata, Osaka, Japan. Electronic address: yagir@hirakata.kmu.ac.jp.</nlm:affiliation></affiliation></author><author><name sortKey="Kariya, Shuji" sort="Kariya, Shuji" uniqKey="Kariya S" first="Shuji" last="Kariya">Shuji Kariya</name><affiliation><nlm:affiliation>Department of Radiology, Kansai Medical University, Hirakata, Osaka, Japan.</nlm:affiliation></affiliation></author><author><name sortKey="Ha Kawa, Sangkil" sort="Ha Kawa, Sangkil" uniqKey="Ha Kawa S" first="Sangkil" last="Ha-Kawa">Sangkil Ha-Kawa</name><affiliation><nlm:affiliation>Department of Radiology, Kansai Medical University, Hirakata, Osaka, Japan.</nlm:affiliation></affiliation></author><author><name sortKey="Tanigawa, Noboru" sort="Tanigawa, Noboru" uniqKey="Tanigawa N" first="Noboru" last="Tanigawa">Noboru Tanigawa</name><affiliation><nlm:affiliation>Department of Radiology, Kansai Medical University, Hirakata, Osaka, Japan.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Techniques in vascular and interventional radiology</title><idno type="eISSN">1557-9808</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Female</term><term>Humans</term><term>Lymphatic Diseases (diagnostic imaging)</term><term>Lymphatic Diseases (etiology)</term><term>Lymphatic Diseases (physiopathology)</term><term>Lymphatic System (diagnostic imaging)</term><term>Lymphatic System (physiopathology)</term><term>Lymphoscintigraphy (adverse effects)</term><term>Lymphoscintigraphy (instrumentation)</term><term>Lymphoscintigraphy (methods)</term><term>Male</term><term>Middle Aged</term><term>Predictive Value of Tests</term><term>Prognosis</term><term>Radiopharmaceuticals (administration & dosage)</term><term>Risk Factors</term><term>Severity of Illness Index</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Radiopharmaceuticals</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lymphoscintigraphy</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Lymphatic Diseases</term><term>Lymphatic System</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphatic Diseases</term></keywords><keywords scheme="MESH" qualifier="instrumentation" xml:lang="en"><term>Lymphoscintigraphy</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Lymphoscintigraphy</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Lymphatic Diseases</term><term>Lymphatic System</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Predictive Value of Tests</term><term>Prognosis</term><term>Risk Factors</term><term>Severity of Illness Index</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lymphoscintigraphy has introduced with the great advantage for diagnostic imaging of the lymphatic flow disorders. Lymphoscintigraphy can be performed in patients of any age, including neonates, and even in patient in critical conditions. The procedure is quite simple, and it needs only subcutaneous injection of small amounts of radiotracers. From subcutaneous tissue the radiotracer is taken by the lymphatic vessels and gives off energy in the form of gamma radiation detected by a gamma camera. Radiotracers rarely cause the allergic reaction and can be administered to the patients with allergy to iodine contrast media. Comparing with the Lipiodol, radiotracers cannot cause pulmonary embolism; therefore, it is safe for the patients with respiratory dysfunction. The objective of this article is to describe the indication, technique, equipment, pitfalls, safety, and effectiveness of lymphoscintigraphy for imaging of the lymphatic flow disorders.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27993322</PMID><DateCreated><Year>2016</Year><Month>12</Month><Day>20</Day></DateCreated><DateCompleted><Year>2017</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2017</Year><Month>04</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-9808</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>4</Issue><PubDate><Year>2016</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Techniques in vascular and interventional radiology</Title><ISOAbbreviation>Tech Vasc Interv Radiol</ISOAbbreviation></Journal><ArticleTitle>Lymphoscintigraphy for Imaging of the Lymphatic Flow Disorders.</ArticleTitle><Pagination><MedlinePgn>273-276</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1089-2516(16)30048-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.tvir.2016.10.009</ELocationID><Abstract><AbstractText>Lymphoscintigraphy has introduced with the great advantage for diagnostic imaging of the lymphatic flow disorders. Lymphoscintigraphy can be performed in patients of any age, including neonates, and even in patient in critical conditions. The procedure is quite simple, and it needs only subcutaneous injection of small amounts of radiotracers. From subcutaneous tissue the radiotracer is taken by the lymphatic vessels and gives off energy in the form of gamma radiation detected by a gamma camera. Radiotracers rarely cause the allergic reaction and can be administered to the patients with allergy to iodine contrast media. Comparing with the Lipiodol, radiotracers cannot cause pulmonary embolism; therefore, it is safe for the patients with respiratory dysfunction. The objective of this article is to describe the indication, technique, equipment, pitfalls, safety, and effectiveness of lymphoscintigraphy for imaging of the lymphatic flow disorders.</AbstractText><CopyrightInformation>Copyright © 2016 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yoshida</LastName><ForeName>Rie Yagi</ForeName><Initials>RY</Initials><AffiliationInfo><Affiliation>Department of Radiology, Kansai Medical University, Hirakata, Osaka, Japan. Electronic address: yagir@hirakata.kmu.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kariya</LastName><ForeName>Shuji</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Radiology, Kansai Medical University, Hirakata, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ha-Kawa</LastName><ForeName>Sangkil</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Radiology, Kansai Medical University, Hirakata, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanigawa</LastName><ForeName>Noboru</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Radiology, Kansai Medical University, Hirakata, Osaka, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Tech Vasc Interv Radiol</MedlineTA><NlmUniqueID>9806675</NlmUniqueID><ISSNLinking>1557-9808</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019275">Radiopharmaceuticals</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008206" MajorTopicYN="N">Lymphatic Diseases</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008208" MajorTopicYN="N">Lymphatic System</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061305" MajorTopicYN="N">Lymphoscintigraphy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019275" MajorTopicYN="N">Radiopharmaceuticals</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Chylothrax</Keyword><Keyword MajorTopicYN="Y">Lympatic leakage</Keyword><Keyword MajorTopicYN="Y">Lymphatic flow</Keyword><Keyword MajorTopicYN="Y">Lymphedema</Keyword><Keyword MajorTopicYN="Y">Lymphoscintigraphy</Keyword><Keyword MajorTopicYN="Y">Tc-99m albumin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27993322</ArticleId><ArticleId IdType="pii">S1089-2516(16)30048-8</ArticleId><ArticleId IdType="doi">10.1053/j.tvir.2016.10.009</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000455 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000455 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:27993322
|texte= Lymphoscintigraphy for Imaging of the Lymphatic Flow Disorders.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:27993322" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |